Status:
COMPLETED
Effect of Digital Technologies on Risk Factor Modification
Lead Sponsor:
Tomsk National Research Medical Center of the Russian Academy of Sciences
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
DigTech investigates the effect of a text message-based intervention to encourage lifestyle change on objective measures of cardiovascular risk in individuals with coronary heart disease (CHD) after p...
Detailed Description
DESIGN: DigTech is a parallel-group, single-blind, randomized clinical trial investigating the changes in cardiovascular risk factors (low-density lipoprotein cholesterol \[LDL-C\] level, blood pressu...
Eligibility Criteria
Inclusion
- Patients with coronary artery disease at the age of 18 to 75 years who are planning PCI for hemodynamically significant coronary artery stenosis.
Exclusion
- Severe comorbidities (malignant tumors, severe lung diseases, marked cognitive impairment).
- Severe CHF (EF LV \<35% or functional class of heart failure III-IV NYHA).
- Severe valvular heart disease or Prosthetic heart valves.
- Severe diseases of the musculoskeletal system.
- The patient's reluctance to participate in the study.
Key Trial Info
Start Date :
March 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT03871907
Start Date
March 11 2019
End Date
December 1 2021
Last Update
April 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science
Tyumen, Russia, 625026